SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SYNTHETECH - NZYM -- Ignore unavailable to you. Want to Upgrade?

To: Dan Gibbs who wrote (329)5/11/2000 12:21:00 PM
From: tuck  Respond to of 372
 
Dan,

That sounds right. Gracias. But it seems to silly me that small batches of peptides might be needed to develop these compounds. And perhaps the same goes for the "proteinomics" companies. Even if I'm granted that long shot, it's still not a huge market, though.

Re: earnings: FWIW:

biz.yahoo.com

Cheers, Tuck



To: Dan Gibbs who wrote (329)6/2/2000 1:57:00 PM
From: tuck  Read Replies (1) | Respond to of 372
 
Dan,

According to Yahoo! the estimate was for .02 and NZYM made .03. +50% is a big surprise, but NZYM continues to frustrate and sell off as Sreeni's forward guidance was no more encouraging than before.

siliconinvestor.com

Cheers, Tuck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News